StonvexLoading…
StonvexStonvexStonvexCore line items from INVH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 | Q3 2018 2018-09-30 | Q2 2018 2018-06-30 |
|---|---|---|---|---|---|
Revenue | $705.27M | $43.74M | $0.00 | $86.57M | $56.45M |
Operating Income | Not available | Not available | Not available | $228.71M | $144.95M |
Net Income | Not available | $160.51M | $165.75M | $-30.20M | $-31.21M |
EPS (Diluted) | $0.18 | $0.26 | $0.27 | $0.00 | $-0.03 |
Total Assets | Not available | $18.70B | $18.58B | $18.48B | $18.67B |
Total Liabilities | Not available | $9.57B | $8.82B | $9.91B | $10.08B |
Cash & Equivalents | Not available | $114.13M | $84.39M | $130.04M | $166.87M |
Free Cash Flow OCF − CapEx | Not available | Not available | $293.31M | $509.53M | $308.50M |
Shares Outstanding | Not available | 593.98M | 612.88M | 520.58M | 520.49M |